This article was originally published on Stateline. The giant tax and spending bill President Donald Trump signed into law over the weekend includes the biggest health care spending cuts in U.S.

We report, for the first time to the best of our knowledge, the largest cohort of serial hs-TnI surveillance in patients diagnosed with cancer and treated with ICIs therapies,” the researchers wrote.

The composition of the gut microbiome appears to be associated with treatment response in patients with pancreatic cancer, research suggests.

The annual growth in national health spending is expected to be higher than average gross domestic product growth in the US during 2024-2033.

Results of a meta-analysis suggest that ctDNA positivity is a “biomarker for poor postoperative recurrence and survival outcomes in NSCLC patients,” researchers wrote.

In May, the FDA granted approvals for Avmapki (avutometinib) and Fakzynja (defactinib), Emrelis (telisotuzumab vedotin-tllv), Welireg (belzutifan), and Zynyz (retifanlimab-dlwr).

Liver metastases are common and associated with a poor prognosis, but there are multiple treatment options, including surgery, chemotherapy, ablation, and radiation therapies.